These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 24123697)
1. Bone marrow uptake of ferumoxytol: a preliminary study in healthy human subjects. Storey P; Arbini AA J Magn Reson Imaging; 2014 Jun; 39(6):1401-10. PubMed ID: 24123697 [TBL] [Abstract][Full Text] [Related]
2. MRI assessment of hepatic iron clearance rates after USPIO administration in healthy adults. Storey P; Lim RP; Chandarana H; Rosenkrantz AB; Kim D; Stoffel DR; Lee VS Invest Radiol; 2012 Dec; 47(12):717-24. PubMed ID: 23070094 [TBL] [Abstract][Full Text] [Related]
3. Ultrasmall superparamagnetic iron-oxide-enhanced MR imaging of normal bone marrow in rodents: original research original research. Simon GH; Raatschen HJ; Wendland MF; von Vopelius-Feldt J; Fu Y; Chen MH; Daldrup-Link HE Acad Radiol; 2005 Sep; 12(9):1190-7. PubMed ID: 16099684 [TBL] [Abstract][Full Text] [Related]
4. Ferumoxytol-enhanced magnetic resonance imaging methodology and normal values at 1.5 and 3T. Stirrat CG; Alam SR; MacGillivray TJ; Gray CD; Forsythe R; Dweck MR; Payne JR; Prasad SK; Petrie MC; Gardner RS; Mirsadraee S; Henriksen PA; Newby DE; Semple SI J Cardiovasc Magn Reson; 2016 Jul; 18(1):46. PubMed ID: 27465647 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Three Ultrasmall, Superparamagnetic Iron Oxide Nanoparticles for MRI at 3.0 T. Colbert CM; Ming Z; Pogosyan A; Finn JP; Nguyen KL J Magn Reson Imaging; 2023 Jun; 57(6):1819-1829. PubMed ID: 36250695 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the novel USPIO GEH121333 for MR imaging of cancer immune responses. Shi Q; Pisani LJ; Lee YK; Messing S; Ansari C; Bhaumik S; Lowery L; Lee BD; Meyer DE; Daldrup-Link HE Contrast Media Mol Imaging; 2013; 8(3):281-8. PubMed ID: 23606432 [TBL] [Abstract][Full Text] [Related]
7. Differential uptake of ferumoxtran-10 and ferumoxytol, ultrasmall superparamagnetic iron oxide contrast agents in rabbit: critical determinants of atherosclerotic plaque labeling. Yancy AD; Olzinski AR; Hu TC; Lenhard SC; Aravindhan K; Gruver SM; Jacobs PM; Willette RN; Jucker BM J Magn Reson Imaging; 2005 Apr; 21(4):432-42. PubMed ID: 15779033 [TBL] [Abstract][Full Text] [Related]
9. Imaging of myocardial infarction using ultrasmall superparamagnetic iron oxide nanoparticles: a human study using a multi-parametric cardiovascular magnetic resonance imaging approach. Yilmaz A; Dengler MA; van der Kuip H; Yildiz H; Rösch S; Klumpp S; Klingel K; Kandolf R; Helluy X; Hiller KH; Jakob PM; Sechtem U Eur Heart J; 2013 Feb; 34(6):462-75. PubMed ID: 23103659 [TBL] [Abstract][Full Text] [Related]
10. Iron-oxide-enhanced MR imaging of bone marrow in patients with non-Hodgkin's lymphoma: differentiation between tumor infiltration and hypercellular bone marrow. Daldrup-Link HE; Rummeny EJ; Ihssen B; Kienast J; Link TM Eur Radiol; 2002 Jun; 12(6):1557-66. PubMed ID: 12042968 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of an fMRI USPIO-based assay in healthy human volunteers. Baumgartner R; Cho W; Coimbra A; Chen C; Wang Z; Struyk A; Venketasubramanian N; Low M; Gargano C; Zhao F; Williams D; Reese T; Seah S; Feng D; Apreleva S; Petersen E; Evelhoch JL J Magn Reson Imaging; 2017 Jul; 46(1):124-133. PubMed ID: 27775841 [TBL] [Abstract][Full Text] [Related]
12. Imaging behavior of the normal adrenal on ferumoxytol-enhanced MRI: preliminary findings. Gunn AJ; Seethamraju RT; Hedgire S; Elmi A; Daniels GH; Harisinghani MG AJR Am J Roentgenol; 2013 Jul; 201(1):117-21. PubMed ID: 23789664 [TBL] [Abstract][Full Text] [Related]
13. Macrophage activity in infected areas of an experimental vertebral osteomyelitis model: USPIO-enhanced MR imaging--feasibility study. Bierry G; Jehl F; Boehm N; Robert P; Prévost G; Dietemann JL; Desal H; Kremer S Radiology; 2008 Jul; 248(1):114-23. PubMed ID: 18458246 [TBL] [Abstract][Full Text] [Related]
14. Brain iron deposition after Ferumoxytol-enhanced MRI: A study of Porcine Brains. Theruvath AJ; Aghighi M; Iv M; Nejadnik H; Lavezo J; Pisani LJ; Daldrup-Link HE Nanotheranostics; 2020; 4(4):195-200. PubMed ID: 32637297 [TBL] [Abstract][Full Text] [Related]
15. Imaging of macrophages in soft-tissue infection in rats: relationship between ultrasmall superparamagnetic iron oxide dose and MR signal characteristics. Lutz AM; Weishaupt D; Persohn E; Goepfert K; Froehlich J; Sasse B; Gottschalk J; Marincek B; Kaim AH Radiology; 2005 Mar; 234(3):765-75. PubMed ID: 15665219 [TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging of experimental atherosclerotic plaque: comparison of two ultrasmall superparamagnetic particles of iron oxide. Herborn CU; Vogt FM; Lauenstein TC; Dirsch O; Corot C; Robert P; Ruehm SG J Magn Reson Imaging; 2006 Aug; 24(2):388-93. PubMed ID: 16791857 [TBL] [Abstract][Full Text] [Related]
17. Quantitative effects of cell internalization of two types of ultrasmall superparamagnetic iron oxide nanoparticles at 4.7 T and 7 T. Brisset JC; Desestret V; Marcellino S; Devillard E; Chauveau F; Lagarde F; Nataf S; Nighoghossian N; Berthezene Y; Wiart M Eur Radiol; 2010 Feb; 20(2):275-85. PubMed ID: 19705124 [TBL] [Abstract][Full Text] [Related]
19. Ultrasmall supraparamagnetic iron oxide-enhanced magnetic resonance imaging of antigen-induced arthritis: a comparative study between SHU 555 C, ferumoxtran-10, and ferumoxytol. Simon GH; von Vopelius-Feldt J; Fu Y; Schlegel J; Pinotek G; Wendland MF; Chen MH; Daldrup-Link HE Invest Radiol; 2006 Jan; 41(1):45-51. PubMed ID: 16355039 [TBL] [Abstract][Full Text] [Related]
20. Improved Detection of Bone Metastases in Children and Young Adults with Ferumoxytol-enhanced MRI. Rashidi A; Baratto L; Theruvath AJ; Greene EB; Jayapal P; Hawk KE; Lu R; Seekins J; Spunt SL; Pribnow A; Daldrup-Link HE Radiol Imaging Cancer; 2023 Mar; 5(2):e220080. PubMed ID: 36999999 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]